CHASE WILLIAM J Insider Trades

Insider Trading History

Track insider trading activity for CHASE WILLIAM J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
GRAIL
GRAIL GRAL
Director
Holding Value $3.12M 42,702 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 5,491 shares
$63.74
$73.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $1.88M 143,893 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.04
GRAIL
GRAIL GRAL
Director
Holding Value $2.72M 37,211 shares
Last Trade
Apr 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.3k 408 shares
$49.79
$73.12
GRAIL
GRAIL GRAL
Director
Holding Value $2.69M 36,803 shares
Last Trade
Jan 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.8k 213 shares
$97.44
$73.12
GRAIL
GRAIL GRAL
Director
Holding Value $2.68M 36,590 shares
Last Trade
Oct 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.8k 275 shares
$75.52
$73.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $1.76M 134,693 shares
Last Trade
Aug 20, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1M 100,000 shares
$10.03
$13.04
GRAIL
GRAIL GRAL
Director
Holding Value $2.66M 36,315 shares
Last Trade
Jul 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5k 533 shares
$38.53
$73.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $452k 34,693 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95.8k 11,450 shares
$8.37
$13.04
GRAIL
GRAIL GRAL
Director
Holding Value $2.62M 35,782 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 6,082 shares
$41.10
$73.12
GRAIL
GRAIL GRAL
Director
Holding Value $2.17M 29,700 shares
Last Trade
Apr 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.3k 784 shares
$25.94
$73.12
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $348k 26,693 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 11,515 shares
$25.85
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $247k 18,956 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 2,447 shares
$45.20
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $225k 17,283 shares
Last Trade
Apr 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$570k 14,931 shares
$38.16
$13.04
Abbvie
Abbvie ABBV
Evp, Finance & Administration
Holding Value $41.4M 169,552 shares
Last Trade
Jun 26, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.05M 30,400 shares
$67.30
$244.22
Abbvie
Abbvie ABBV
Evp, Finance & Administration
Holding Value $34M 139,152 shares
Last Trade
Feb 28, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.17M 27,276 shares
$79.41
$244.22
Abbvie
Abbvie ABBV
Evp, Finance & Administration
Holding Value $31M 127,013 shares
Last Trade
Feb 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.74M 22,150 shares
$78.75
$244.22
Abbvie
Abbvie ABBV
Evp, Finance & Administration
Holding Value $40.6M 166,428 shares
Last Trade
Feb 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$668k 8,481 shares
$78.75
$244.22
Abbvie
Abbvie ABBV
Evp, Finance & Administration
Holding Value $14.8M 60,747 shares
Last Trade
Feb 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.8M 60,747 shares
$79.02
$244.22
Abbvie
Abbvie ABBV
Evp, Finance & Administration
Holding Value $34.9M 142,958 shares
Last Trade
Feb 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 15,945 shares
$78.75
$244.22
Abbvie
Abbvie ABBV
Evp, Finance & Administration
Holding Value $38.6M 157,947 shares
Last Trade
Feb 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 14,989 shares
$78.75
$244.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up